Mwandishi:
Mhariri:
ULY CLINIC
Dkt. Peter A, MD
16 Juni 2021 18:59:21
Ceftriaxone na ujauzito
Ceftriaxone ni dawa ya antibiotiki ya kuchoma iliyo katika kundi la cephalosporin. Tafiti za panya zimeonyesha dawa haina madhara kwenye uzazi kwenye dozi iliyotumika ambayo ni sawa na mara 20 ya dozi inayotakiwa kutumika kwa binadamu, panya, na nyani.
Kiasi kidogo huingia kwenye maziwa ya mama na humpata mtoto na kuleta madhara ya kubadilisha bakteria rafiki kwenye mfumo wa tumbo la mtoto, kutoa majibu ya kuotesha bakteria yasiyo sahihi endapo mtoto ana homa na madhara ya moja kwa moja kwa mtoto. Hata hivyo wataaluma wameweka dawa hii kuwa salama kutumika kwa mama aonyonyesha.
Ushauri dhidi ya matumizi kwa mama mjamzito
Inapatana na ujauzito
Inapatana na ujauzito ina maanisha nini?
Uzoefu wa matumizi kwa binadamu kuhusu dawa hii au dawa zingine zilizo kundi moja au zenye kufanya kazi kwa utaratibu unaofanana, zinatosha kuonyesha kuwa, madhara kwa kichanga tumboni ni madogo sana au hakuna kabisa. Tafiti za uzazi kwa wanyama hazina uhalisia kwa binadamu.
Ushauri wa matumizi kwa mama anayenyonyesha
Inapatana na unyonyeshaji
Inapatana na unyonyeshaji ina maanisha nini?
Kiasi kidogo cha dawa hii kinawezekana kuingia kwenye maziwa ya mama, kiasi hiki hakina mashiko ya kusababisha sumu kwa kichanga anayenyonya. Dawa hii haitarajiwi kusababisha madhara kwa kichanga anayenyonya maziwa ya mama anayetumia dawa hii.
ONYO: Usitumie dawa yoyote bila ushauri wa daktari. Dawa zinaweza kuleta madhara mwilini na pia matumizi ya baadhi ya dawa pasipo ushauri na vipimo husababisha vimelea kuwa sugu dhidi ya dawa hiyo.
ULY clinic inakushauri kuwasiliana na daktari wako unapotaka kuchukua maamuzi yoyote yanayohusu afya yako.
Wasiliana na daktari/Mfamasia wa ULY clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kupiga simu au Kubonyeza Pata tiba chini ya tovuti hii.
Imeboreshwa,
1 Julai 2023 17:20:41
Rejea za mada hii
1. Product information. Rocephin. Roche Laboratories, 1997.
2. Bourget P, Fernandez H, Quinquis V, Delouis C. Pharmacokinetics and protein binding of ceftriaxone during pregnancy. Antimicrob Agents Chemother 1993;37:54–9.
3. Kafetzis DA, Brater DC, Fanourgakis JE, Voyatzis J, Georgakopoulos P. Placental and breast-milk transfer of ceftriaxone (C). In: Proceedings of the 22nd Interscience Conference on Antimicrobial Agents in Chemotherapy, Miami, FL, October 4–6, 1982. New York, NY: Academic Press, 1983:155.
4. Kafetzis DA, Brater DC, Fanourgakis JE, Voyatzis J, Georgakopoulos P. Ceftriaxone distribution between maternal blood and fetal blood and tissues at parturition and between blood and milk postpartum. Antimicrob Agents Chemother 1983;23:870–3.
5. Cho N, Kunii K, Fukunago K, Komoriyama Y. Antimicrobial activity, pharmacokinetics and clinical studies of ceftriaxone in obstetrics and gynecology. In: Proceedings of the 13th International Congress on Chemotherapy, Vienna, Austria, August 28–September 2, 1983 . Princeton, NJ: Excerpta Medica,1984:100/64–6.
6. Graber H, Magyar T. Pharmacokinetics of ceftriaxone in pregnancy. Am J Med 1984;77:117–8.
7. Sanchez-Ramos L, McAlpine KJ, Adair CD, Kaunitz AM, Delke I, Briones DK. Pyelonephritis in pregnancy: once-a-day ceftriaxone versus multiple doses of cefazolin. Am J Obstet Gynecol 1995;172:129–33.
8. Lang R, Shalit I, Segal J, Arbel Y, Markov S, Hass H, Fejgin M. Maternal and fetal and tissue levels of ceftriaxone following preoperative prophylaxis in emergency cesarean section. Chemotherapy 1993;39:77–81.
9. Cavenee MR, Farris JR, Spalding TR, Barnes DL, Castaneda YS, Wendel GD Jr. Treatment of gonorrhea in pregnancy. Obstet Gynecol 1993;81:33–8.
10. Deger R, Ludmir J. Neisseria sicca endocarditis complicating pregnancy. A case report. J Reprod Med 1992;37:473–5.
11. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776–89.